• Users Online: 46
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2020  |  Volume : 6  |  Issue : 1  |  Page : 68

Candida auris candidemia – An emerging threat: A case report and mini-review of the literature

Department of Paediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq

Date of Submission17-Jan-2020
Date of Decision05-Mar-2020
Date of Acceptance22-Mar-2020
Date of Web Publication20-Jul-2020

Correspondence Address:
Mahmood Dhahir Al-Mendalawi
P.O. Box 55302, Baghdad Post Office, Baghdad
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcrsm.jcrsm_3_20

Rights and Permissions

How to cite this article:
Al-Mendalawi MD. Candida auris candidemia – An emerging threat: A case report and mini-review of the literature. J Curr Res Sci Med 2020;6:68

How to cite this URL:
Al-Mendalawi MD. Candida auris candidemia – An emerging threat: A case report and mini-review of the literature. J Curr Res Sci Med [serial online] 2020 [cited 2022 Dec 8];6:68. Available from: https://www.jcrsmed.org/text.asp?2020/6/1/68/290247

Dear Sir,

I read with interest the case report by Bhat et al.[1] published in the July–December 2019 issue of the Journal of Current Research in Scientific Medicine. The authors studied a case of the Candida auris candidemia in an Indian patient. The authors attributed the escalating clinical course culminating in death to the presence of numerous comorbidities in the studied patient, namely obstructive sleep apnea, rheumatic heart disease with mitral stenosis, cholelithiasis, and hypothyroidism. I assume that the following point might be contributory. It is obvious that due to defective immune system, individuals with human immunodeficiency virus (HIV) infection are more liable to various types of fungal infections compared to the individuals with intact immune system. Truly, fungal infections among HIV-positive individuals tend to be invasive and often run protracted clinical progressions.[2] In India, HIV infection is a worrisome health threat. The available data pointed out that the national adult HIV seroprevalence was estimated at 0.22% (0.16%–0.30%) in 2017.[3] I presume that underlying HIV infection ought to be seriously considered in the case in question and diagnostic algorithm for HIV detection would have solicited. If that algorithm was to disclose HIV seropositivity, the case in question could be obviously regarded a novel case report. This is because C. auris fungal isolate has never been reported among Indian patients infected with HIV.[4] Regrettably, the studied patient succumbed before considering HIV testing.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Bhat KS, Kisku KH, Kanungo R. Candida auris candidemia an emerging threat: A case report and mini review of the literature. J Curr Res Sci Med 2019;5:110-3.  Back to cited text no. 1
  [Full text]  
Guarner J. Human immunodeficiency virus and fungal infections. Semin Diagn Pathol 2017;34:325-31.  Back to cited text no. 2
Government of India, Ministry of Health and Family Welfare, National Aids Control Organisation. HIV Facts and Figures. Available from: http://naco.gov.in/hiv-facts-figures. [Last accessed on 2020 Jan 16].  Back to cited text no. 3
Maheshwari M, Kaur R, Chadha S. Candida Species prevalence profile in HIV seropositive patients from a major tertiary care hospital in New Delhi, India. J Pathog 2016;2016:6204804.  Back to cited text no. 4


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded143    
    Comments [Add]    

Recommend this journal